Investigating the Effects of Intervention Strategies on Pneumonia and HIV/AIDS Coinfection Model
Shewafera Wondimagegnhu Teklu1
1Department of Mathematics, Natural Science, Debre Berhan University, Debre Berhan, Ethiopia.
Abstract:
HIV/AIDS and pneumonia coinfection have imposed a major socioeconomic and health burden throughout the world, especially in the developing countries. In this study, we propose a compartmental epidemic model on the spreading dynamics of HIV/AIDS and pneumonia coinfection to investigate the impacts of protection and treatment intervention mechanisms on the coinfection spreading in the community. In the qualitative analysis of the model, we have performed the positivity and boundedness of the coinfection model solutions; the effective reproduction numbers using the next-generation operator approach; and both the disease-free and endemic equilibrium points' local and global stabilities using the Routh-Hurwiz and Castillo-Chavez stability criteria, respectively. We performed the sensitivity analysis of the model parameters using both the forward normalized sensitivity index criteria and numerical methods (simulation). Moreover, we carried out the numerical simulation for different scenarios to investigate the effect of model parameters on the associated reproduction number, the effect of model parameters on the model state variables, and the solution behavior and convergence to the equilibrium point(s) of the models. Finally, from the qualitative analysis and numerical simulation results, we observed that the disease-spreading rates, protection rates, and treatment rates are the most sensitive parameters, and we recommend for stakeholders to concentrate and exert their maximum effort to minimize the spreading rates by maximizing the protection and treatment rates.
More Related Videos
08:14An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Retrovirus Life Cycles
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
